
Waycen is a medical technology company specializing in AI-based precision medical platforms for the entire cancer life cycle. It develops innovative AI medical solutions essential for full-cycle cancer diagnosis and treatment, leveraging world-class AI technology. The company collaborates with leading domestic hospitals and institutions for joint research and development, enhancing cancer detection and treatment accuracy. Its flagship product, WAYMED endo, is a real-time image analysis medical device for gastrointestinal endoscopy that improves early cancer detection and examination accuracy without requiring internet connectivity or new equipment. Waycen has received multiple certifications and awards, including medical device certifications and innovation awards, and is recognized as a future unicorn company in South Korea.

Waycen is a medical technology company specializing in AI-based precision medical platforms for the entire cancer life cycle. It develops innovative AI medical solutions essential for full-cycle cancer diagnosis and treatment, leveraging world-class AI technology. The company collaborates with leading domestic hospitals and institutions for joint research and development, enhancing cancer detection and treatment accuracy. Its flagship product, WAYMED endo, is a real-time image analysis medical device for gastrointestinal endoscopy that improves early cancer detection and examination accuracy without requiring internet connectivity or new equipment. Waycen has received multiple certifications and awards, including medical device certifications and innovation awards, and is recognized as a future unicorn company in South Korea.